Vermont Tech Scene: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.

Press releases published on October 30, 2026

2 hours ago

Aer Therapeutics Announces Top-Line Results from its Phase 2a Proof-of-Concept Trial of Fexlamose in Chronic Obstructive Pulmonary Disease (“COPD”)

Indeterminate GlobeNewswire

2 hours ago

Vor Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

2 hours ago

INDROTEK Discusses Relevance of OVIN Dual-Use Technology Findings to Its Robotics and Defense Activities

Indeterminate GlobeNewswire

2 hours ago

Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study

Indeterminate GlobeNewswire

2 hours ago

Core AI Holdings Appoints Haggai Ravid to Board of Directors

Indeterminate GlobeNewswire

2 hours ago

Gix Internet: deliverz.ai Granted Patent in South Korea, Expanding International Navigation IP Protection

Indeterminate GlobeNewswire

2 hours ago

Braveheart Bio to Host Webinar – HCM Spotlight: Advancing a Next-Generation Cardiac Myosin Inhibitor – with Key Opinion Leader Discussion on November 6, 2026

Indeterminate GlobeNewswire

2 hours ago

Braveheart Bio Announces Upcoming Presentations at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

3 hours ago

Alterity Therapeutics Releases Appendix 4C – Q1 FY27 Quarterly Cash Flow Report & Corporate Update

Indeterminate GlobeNewswire

3 hours ago

Syndax Announces Participation in November Investor Conferences

Indeterminate GlobeNewswire

3 hours ago

Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint

Indeterminate GlobeNewswire

3 hours ago

NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date

Indeterminate GlobeNewswire

3 hours ago

Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA

Indeterminate GlobeNewswire

3 hours ago

Agility Robotics and Churchill Capital Corp XI Announce Expected Gross Capital Raise of Approximately $465 Million and Anticipated Closing of Business Combination

Indeterminate GlobeNewswire

3 hours ago

Aurora Mobile’s Modellix.ai Brings Unified AI Model Access to ComfyUI Creative Workflows

Indeterminate GlobeNewswire

3 hours ago

Regeneron Reports Third Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

3 hours ago

LyondellBasell agrees to sell former refinery site in Houston

Indeterminate GlobeNewswire

4 hours ago

CT UAV Determined Not to Be Outdone by Germany or Japan

Indeterminate GlobeNewswire

4 hours ago

Repligen Announces $1 Billion Private Convertible Senior Notes Transaction

Indeterminate GlobeNewswire

4 hours ago

Emdoor Information Expands Rugged AI PC Portfolio for Intelligent Edge Applications

Indeterminate GlobeNewswire